As the ABPI publishes its latest skills survey, Carole Longson says that we need attract more young people into careers in life sciences, particularly post-Brexit
On World Antibiotic Awareness Day, Public Affairs Manager Harriet Adams gives some key facts which illustrate the need to act now to address the challenge of antibiotic resistance.
Julian Sturdy MP, Chair of the All-Party Parliamentary Group on Antibiotics, explains why AMR should remain a key issue for the Government.
Pharmaceutical companies continue to plan for the UK’s exit from the EU. As they do, the terms on which the UK will leave - and the terms of the future relationship – remain uncertain.
As Britain Brexits from the EU, it’s going to be more important than ever that the UK convincingly demonstrates to the world that it embraces new innovations.
With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.
Awarding of funding for medicines manufacturing this week marks the next step in Industry and government’s joint ambition for securing the UK’s life sciences sector.